Global Drug Revenue (Row 2 - 6)
The global yearly revenue for acetaminophen, albuterol aerosol, alendronate sodium, and alprazolam as reported in 2017 is:
Albuterol aerosol: $121M
Alendronate sodium: $241M
After extensively researching brand and parent company websites, pharmaletters, medical research websites, and pharmaceutical websites, we determined that the global revenue of atenolol is not publicly available. Data regarding the drug's annual revenue in the United States (its largest market), however, is available. The yearly annual U.S. revenue of atenolol as reported in 2017 was $70M.
All information regarding these 5 drugs is provided in rows 2-6 of the attached spreadsheet.
The trade name of alendronate sodium is Fosamax. Revenue data is most often reported under the trade name.
The trade name of alprazolam is Xanax. Revenue data is most often reported under the trade name.
The trade name of acetaminophen is paracetamol. Revenue data is most often reported under the trade name.